Abstract
Erik Renström and colleagues discuss a new mouse study that explores the mechanism behind the secondary failure of sulfonylurea treatment.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Humans
-
Hypoglycemic Agents / therapeutic use*
-
Mice
-
Sulfonylurea Compounds / therapeutic use*
-
Treatment Outcome
Substances
-
Hypoglycemic Agents
-
Sulfonylurea Compounds